Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.

Detalles Bibliográficos
Publicado en:Breast Cancer Research Vol. 25; no. 1; pp. 1 - 12
Autores principales: Löfling, L. Lukas, Støer, Nathalie C., Andreassen, Bettina Kulle, Ursin, Giske, Botteri, Edoardo
Formato: Journal Article
Publicado: BioMed Central 8/30/2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171101421&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 171101421
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14655411
        8UYJ
      jtl: Breast Cancer Research
      issn: 14655411
      maglogo: N
    pubinfo:
      dt: 8/30/2023
      vid: 25
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        171101421
        10.1186/s13058-023-01697-2
        171101421
      ppf: 1
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
      aug:
        au:
          Löfling, L. Lukas
          Støer, Nathalie C.
          Andreassen, Bettina Kulle
          Ursin, Giske
          Botteri, Edoardo
        affil: Department of Research, Cancer Registry of Norway, Postboks 5313 Majorstuen, 0304, Oslo, Norway
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N